| Cat. No. |
Product Name / Activity |
| 2414 |
H 1152 dihydrochloride |
| Selective Rho-kinase (ROCK) inhibitor |
| 2485 |
Glycyl-H 1152 dihydrochloride |
| Selective Rho-kinase (ROCK) inhibitor. More selective analog of H 1152 dihydrochloride (Cat. No. 2414) |
| 6675 |
H 151 |
| STING antagonist |
| 2910 |
H 89 dihydrochloride |
| Protein kinase A inhibitor |
| 6228 |
H10 |
| PARP14 inhibitor; cell-permeable |
| 5935 |
H2DCFDA |
| Fluorescent ROS indicator; cell permeable |
| 4870 |
H2L 5765834 |
| LPA1,3,5 antagonist |
| 4878 |
H2L5186303 |
| Potent and selective LPA2 receptor antagonist |
| 6211 |
H3K27(Me) (15-34) |
| Histone H3 peptide; substrate for demethylase/methyltransferase enzymes |
| 6212 |
H3K27(Me2) (15-34) |
| Histone H3 peptide; substrate for methyltransferase/demethylase enzymes |
| 6213 |
H3K27(Me3) (15-34) |
| Histone H3 peptide; substrate for methyltransferase/demethylase enzymes |
| 0542 |
H-7 dihydrochloride |
| Protein kinase inhibitor |
| 0396 |
H-9 dihydrochloride |
| Protein kinase inhibitor |
| 2415 |
HA 1100 hydrochloride |
| Cell-permeable, selective Rho-kinase inhibitor |
| 4196 |
HA 130 |
| Potent and selective autotaxin inhibitor |
| 1541 |
HA14-1 |
| Bcl-2 inhibitor. Induces apoptosis |
| 0281 |
(R)-(+)-HA-966 |
| NMDA partial agonist/antagonist; acts at glycine site |
| 0282 |
(S)-(-)-HA-966 |
| NMDA antagonist/partial agonist |
| 6647 |
HADA |
| Blue fluorescent D-amino acid for labeling peptidoglycans in live bacteria |
| 4285 |
HBX 41108 |
| Selective USP7 inhibitor |
| 2896 |
HC 030031 |
| Selective TRPA1 blocker |
| 4100 |
HC 067047 |
| Potent and selective TRPV4 antagonist |
| 0535 |
HEAT hydrochloride |
| Highly selective α1 antagonist |
| 1579 |
HEMADO |
| High affinity selective A3 agonist |
| 3173 |
HEPES |
| Multipurpose buffer |
| 3174 |
HEPES Sodium salt |
| Multipurpose buffer |
| 5885 |
HEPPS |
| Used as a buffering agent |
| 5886 |
HEPPSO |
| Buffering agent |
| 5627 |
HFI 142 |
| Insulin-regulated aminopeptidase (IRAP) inhibitor |
| 4555 |
HI TOPK 032 |
| Selective T-LAK-cell-originated protein kinase (TOPK) inhibitor |
| 5961 |
HIOC |
| Selective TrkB receptor agonist; neuroprotectant |
| 2217 |
(±)-HIP-A |
| Potent, non-competitive EAAT inhibitor |
| 2218 |
(±)-HIP-B |
| Potent, non-competitive EAAT inhibitor |
| 4844 |
HJC 0350 |
| Selective Epac2 inhibitor |
| 6110 |
HJC 0416 hydrochloride New |
| STAT3 inhibitor |
| 3580 |
HKI 357 |
| Dual irreversible inhibitor of ErbB2 and EGFR |
| 3503 |
HLI 373 |
| Hdm2 inhibitor; activates p53-dependent transcription |
| 5283 |
HLM 006474 |
| E2F transcription factor inhibitor |
| 5850 |
HM 50316 |
| High affinity FABP4 inhibitor |
| 5011 |
HMR 1556 |
| Potent and selective Iks channel blocker |
| 5154 |
HNGF6A |
| Humanin analog; increases insulin sensitivity |
| 6994 |
HODHBt |
| STAT5-SUMO protein-protein interaction inhibitor |
| 3014 |
HOE 140 |
| Potent and selective B2 antagonist |
| 3839 |
HPI 1 |
| Inhibits Hedgehog signaling |
| 3530 |
HQL 79 |
| Human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor |
| 2192 |
4-HQN |
| PARP inhibitor |
| 1831 |
HS 014 |
| Selective MC4 receptor antagonist |
| 1832 |
HS 024 |
| Highly potent MC4 receptor antagonist |
| 5768 |
HS 38 |
| ATP-competitive inhibitor of DAPK and ZIPK |
| 5622 |
HTH 01-015 |
| Potent and selective NUAK1 inhibitor |
| 0646 |
HTMT dimaleate |
| H1/ H2 agonist |
| 0966 |
HU 210 |
| Highly potent cannabinoid receptor agonist |
| 2861 |
HU 211 |
| NMDA receptor antagonist; also NF-κB inhibitor |
| 3088 |
HU 308 |
| Potent and selective CB2 agonist |
| 3912 |
HX 531 |
| Potent RXR antagonist |
| 3913 |
HX 630 |
| RXR synergist |
| 4991 |
HaXS8 |
| Chemical dimerizer |
| 1993 |
Halofuginone hydrobromide |
| High affinity competitive prolyl-tRNA synthetase inhibitor |
| 0931 |
Haloperidol hydrochloride |
| Dopamine antagonist; displays some D2 selectivity |
| 1132 |
Harmane |
| Putative endogenous imidazoline ligand. Also MAO inhibitor |
| 5075 |
Harmine |
| Potent and selective DYRK1A inhibitor |
| 5433 |
Heclin |
| HECT E3 ubiquitin ligase inhibitor |
| 5222 |
Hematoxylin |
| Histologic stain; used to stain cell nuclei |
| 2576 |
Hemokinin 1 (human) |
| Endogenous and selective NK1 agonist |
| 1535 |
Hemokinin 1 (mouse) |
| Endogenous, high affinity and selective NK1 agonist |
| 3791 |
Hemopressin (human, mouse) |
| Selective CB1 inverse agonist |
| 1764 |
Hemopressin (rat) |
| Selective CB1 inverse agonist |
| 2812 |
Heparin sodium salt |
| Anticoagulant |
| 1629 |
Herbimycin A |
| Src family kinase inhibitor. Also Hsp90 inhibitor |
| 3988 |
Hesperadin hydrochloride |
| Potent Aurora kinase B inhibitor |
| 4711 |
Hexa-D-arginine |
| Furin inhibitor |
| 2291 |
1,2,3,4,5,6-Hexabromocyclohexane |
| Inhibits JAK2 autophosphorylation |
| 4111 |
Hexamethonium bromide |
| Non-competitive nAChR antagonist |
| 0526 |
(±)-Hexanoylcarnitine chloride |
| Intermediate in lipid metabolism |
| 1749 |
HexylHIBO |
| Group I mGlu antagonist |
| 1750 |
(S)-HexylHIBO |
| Group I mGlu antagonist |
| 2994 |
Signal Enhancer Hikari |
| Antibody-antigen signal enhancer |
| 2174 |
Hispidulin |
| Partial positive allosteric modulator at the benzodiazepine site |
| 3545 |
Histamine dihydrochloride |
| Endogenous histamine receptor agonist |
| 1876 |
Histamine H3 Receptor Tocriset™ |
| Selection of 5 histamine H3 receptor ligands (Cat. Nos. 0729, 0569, 0752, 0779 and 0644) |
| 5824 |
Hoechst 33258 |
| Fluorescent dye for labeling DNA |
| 5117 |
Hoechst 33342 |
| Fluorescent dye for labeling DNA |
| 1416 |
Homoharringtonine |
| Inhibitor of protein synthesis. Antileukemic agent |
| 0197 |
Homoquinolinic acid |
| Potent and selective NMDA agonist |
| 2875 |
Homovanillic acid |
| Fluorimetric reagent and major catecholamine metabolite. |
| 4590 |
Honokiol |
| Blocks NF-κB activation; also anti-inflammatory and antioxidant |
| 4718 |
Huwentoxin IV |
| Selective NaV1.7 channel blocker |
| 5235 |
Huwentoxin XVI |
| Potent and reversible CaV2.2 blocker |
| 4093 |
Hydrocortisone |
| Adrenal glucocorticoid; immunosuppressant |
| 5364 |
Hydroxy Dynasore |
| Dynamin inhibitor; analog of dynasore (Cat. No. 2897) |
| 5740 |
6-Hydroxy-DL-DOPA |
| Allosteric inhibitor of RAD52; also APE1 inhibitor |
| 1080 |
(R)-(+)-8-Hydroxy-DPAT hydrobromide |
| Selective 5-HT1A agonist; enantiomer of 8-Hydroxy-DPAT hydrobromide (Cat. No. 0529) |
| 0706 |
7-Hydroxy-DPAT hydrobromide |
| Dopamine agonist (D3 ≥ D2 < > D4) |
| 0529 |
8-Hydroxy-DPAT hydrobromide |
| Selective 5-HT1A agonist; also has moderate affinity for 5-HT7 |
| 0797 |
8-Hydroxy-PIPAT oxalate |
| High affinity 5-HT1A agonist |
| 0183 |
L-(-)-threo-3-Hydroxyaspartic acid |
| Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor |
| 5648 |
Hydroxychloroquine sulfate |
| Autophagy inhibitor; also TLR9 inhibitor |
| 4474 |
20(S)-Hydroxycholesterol |
| Allosteric activator of Hedgehog (Hh) signaling; induces Smo accumulation |
| 5741 |
25-Hydroxycholesterol |
| Antiviral; also α-crystallin (cryAB) chaperone |
| 3907 |
27-Hydroxycholesterol |
| LXR agonist; also ER partial agonist |
| 0538 |
trans-4-Hydroxycrotonic acid |
| GHB receptor ligand |
| 2547 |
6-Hydroxydopamine hydrobromide |
| Selective catecholaminergic neurotoxin |
| 6124 |
(R)-2-Hydroxyglutaric acid disodium salt |
| KDM4A inhibitor; also NF-κB activator |
| 6094 |
2R,6R-Hydroxynorketamine hydrochloride |
| Enhances AMPA currents; decreases D-serine (a NMDA co-agonist); lacks ketamine-related side effects |
| 6095 |
2S,6S-Hydroxynorketamine hydrochloride |
| Decreases D-serine (a NMDA co-agonist); antidepressant |
| 5982 |
cis-6-Hydroxynorketamine hydrochloride |
| Enhances AMPA currents: antidepressant |
| 0290 |
N-(4-Hydroxyphenylacetyl)spermine |
| Wasp toxin analog |
| 0324 |
(RS)-3-Hydroxyphenylglycine |
| Group I mGlu agonist |
| 0326 |
(S)-3-Hydroxyphenylglycine |
| Group I mGlu agonist; active isomer of (RS)-3-Hydroxphenylglycine (Cat. No. 0324) |
| 0708 |
2-Hydroxypropyl-β-cyclodextrin |
| Solubilization agent |
| 0245 |
2-Hydroxysaclofen |
| Selective GABAB antagonist; more potent than Saclofen (Cat. No. 0246) |
| 6406 |
Hydroxystilbamidine bis(methanesulfonate) |
| Displays different fluorescence emission wavelenghts when bound to DNA compared to RNA |
| 3412 |
(Z)-4-Hydroxytamoxifen |
| Metabolite of tamoxifen (Cat. No. 0999) |
| 4137 |
Hygromycin B |
| Aminoglycoside antibiotic; active against prokaryotic and eukaryotic cells |
| 1520 |
Hypericin |
| Inhibits tyrosine kinases |
| 0208 |
Hypotaurine |
| Non-selective endogenous glycine receptor agonist |